Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment-Reference-Cited by-同舟云学术

Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment

Published:2023-04 Issue:4 Volume:7 Page:e863
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Stevens Wendy B. C.¹,Los-de Vries G. Tjitske²,Langois-Jacques Carole³⁴⁵,Clear Andrew J.⁶,Stathi Phylicia²,Sander Birgitta⁷,Rosenwald Andreas⁸⁹,Calaminici Maria⁶,Hoster Eva¹⁰¹¹,Hiddemann Wolfgang¹¹,Gaulard Philippe¹²,Salles Gilles¹³,Klapper Wolfram¹⁴,Xerri Luc¹⁵,Burton Catherine¹⁶,Tooze Reuben M.¹⁷,Smith Alexandra G.¹⁸,Buske Christian¹⁹,Scott David W.²⁰,Natkunam Yasodha²¹²²,Advani Ranjana²²²³,Sehn Laurie H.²⁰,Raemaekers John¹,Gribben John⁶,Lockmer Sandra²⁴,Kimby Eva²⁴,Kersten Marie José²⁵,Maucort-Boulch Delphine³⁴⁵,Ylstra Bauke²,van Dijk Erik²,de Jong Daphne²

Affiliation:

1. Department of Hematology, Radboud UMC Nijmegen, the Netherlands

2. Department of Pathology, Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands

3. Université Lyon 1, Villeurbanne, France

4. CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Villeurbanne, France

5. Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique et Bioinformatique, Lyon, France

6. Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary, University of London, United Kingdom

7. Division of Pathology, Department of Laboratory Medicine, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden

8. Institute of Pathology, University of Würzburg, Germany

9. Comprehensive Cancer Center Mainfranken, Würzburg, Germany

10. Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), LMU University, Munich, Germany

11. Department of Medicine III, LMU University Hospital, Munich, Germany

12. Department of Pathology, Henri Mondor University Hospital, APHP, INSERM U955, Université Paris-Est, Créteil, France

13. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA

14. Institute of Pathology, University of Schleswig-Holstein, Kiel, Germany

15. Département de Biopathologie, Institut Paoli-Calmettes, Marseille, France

16. Haematological Malignancy Diagnostic Service, St James University Hospital, Leeds, United Kingdom

17. Division of Haematology & Immunology, Leeds Institute of Medical Research, University of Leeds, United Kingdom

18. Epidemiology & Cancer Statistics Group, Department of Health Sciences, University of York, United Kingdom

19. Institute of Experimental Cancer Research, CCC Ulm, Universitäts Klinikum Ulm, Germany

20. BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada

21. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA

22. Stanford Cancer Institute, Stanford, CA, USA

23. Department of Hematology, Stanford University School of Medicine, Stanford, CA, USA

24. Division of Hematology, Department of Medicine, Karolinska Institute, Stockholm, Sweden

25. Department of Hematology, Amsterdam UMC location University of Amsterdam, Cancer Center Amsterdam, the Netherlands

Publisher

Wiley

Subject

Hematology

Reference15 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.;Swerdlow;Blood,2016

2. Follicular lymphoma international prognostic index.;Solal-Celigny;Blood,2004

3. Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era.;Nastoupil;Br J Haematol,2016

4. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial.;Ardeshna;Lancet Oncol,2014

5. Influence of the watch and wait strategy on clinical outcomes of patients with follicular lymphoma in the rituximab era.;Yuda;Ann Hematol,2016